Nova Scotia announced on Wednesday the province’s first case of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare blood clotting condition, in someone who received the first dose of the AstraZeneca COVID-19 vaccine.
Editor’s note: The man affected was in his 40s, not 50s, as Dr. Strang says in the clip.